. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: Clin Pharmacol Ther. 2021 Jul 7;110(3):649–661. doi: 10.1002/cpt.2327

Table 1.

Characteristics of implementers of clinical pharmacogenetics (individuals and institutions) that completed the survey

Individuals (n = 15)
Type of Training^*	n (%)
PhD	2 (13%)
PharmD	13 (87%)
Master’s Degree	1 (7%)
Years Since Training Completed
0–5	6 (40%)
6–10	4 (27%)
11–15	3 (20%)
16 or more	2 (13%)
Pharmacogenetics Training^*
None	2 (13%)
Fellowship	9 (60%)
Master’s Degree	1 (7%)
Residency	6 (40%)
Seminars, Workshops, or CME	5 (33%)
Online Training	2 (13%)
Certificate Program	1 (7%)
Institutions (n = 13)
Type of Institution^*
Academic	11 (85%)
Community	3 (23%)
Pharmacogenetic Testing Offered
Broad	6 (46%)
Limited	7 (54%)
None	0 (0%)